CTMX Smart Money
CytomX Therapeutics, Inc.
1W: -8.0%
1M: -14.1%
3M: -27.1%
YTD: -45.6%
1Y: -29.1%
3Y: +73.7%
5Y: -54.2%
$2.31
+0.09 (+3.82%)
Weekly Expected Move ±9.0%
$2
$2
$2
$3
$3
Credit Risk of going bust: lower than 54% of companies Debt: 1.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down 99.8%), CytomX Therapeutics, Inc. would be worth roughly what it owes.
Total debt $5.7M against a stock market value of $503.3M.
Distance to default 5.57 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $3.6M (short-term plus half of long-term), stock volatility 83.9%; Altman Z'' 1.92. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.01 (down 99.8%), CytomX Therapeutics, Inc. would be worth roughly what it owes.
Total debt $5.7M against a stock market value of $503.3M.
Distance to default 5.57 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $3.6M (short-term plus half of long-term), stock volatility 83.9%; Altman Z'' 1.92. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026228
Institutions Holding
+27 vs prior
159.0%
Ownership
-21.30%
49
New
71
Increased
78
Reduced
45
Closed
👔 Insider Trades
22 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-03 | Carvajal Alejandra | officer: chief legal officer | A-Grant/Award | 100,000 | $— | $0 | Filing |
| 2026-06-15 | Ogden Christopher | officer: chief financial officer | S-Sale | 1,624 | $3.05 | $5K | Filing |
| 2026-03-17 | BELVIN MARCIA | officer: svp, chief scientific officer | S-Sale | 31,492 | $6.42 | $202K | Filing |
| 2026-03-17 | Ogden Christopher | officer: chief financial officer | S-Sale | 19,323 | $6.42 | $124K | Filing |
| 2026-03-17 | Chu Yu-Waye | officer: chief medical officer | S-Sale | 21,279 | $6.42 | $137K | Filing |
| 2026-03-17 | McCarthy Sean A. | officer: ceo | S-Sale | 118,969 | $6.42 | $764K | Filing |
| 2026-02-02 | BELVIN MARCIA | officer: svp, chief scientific officer | A-Grant/Award | 60,000 | $— | $0 | Filing |
| 2026-02-02 | Chu Yu-Waye | officer: chief medical officer | A-Grant/Award | 75,000 | $— | $0 | Filing |
| 2026-02-02 | McCarthy Sean A. | officer: ceo | A-Grant/Award | 210,000 | $— | $0 | Filing |
| 2026-02-02 | Ogden Christopher | officer: chief financial officer | A-Grant/Award | 90,000 | $— | $0 | Filing |
| 2026-02-02 | Lester Rachael | officer: chief business officer | A-Grant/Award | 20,000 | $— | $0 | Filing |
| 2025-11-06 | McCarthy Sean A. | officer: ceo | S-Sale | 101,793 | $4.54 | $462K | Filing |
| 2025-11-06 | McCarthy Sean A. | officer: ceo | S-Sale | 101,793 | $4.54 | $462K | Filing |
| 2025-06-16 | BELVIN MARCIA | officer: svp, chief scientific officer | S-Sale | 13,884 | $2.69 | $37K | Filing |
| 2025-06-16 | McCarthy Sean A. | officer: ceo | S-Sale | 55,511 | $2.69 | $149K | Filing |
| 2025-06-16 | Ogden Christopher | officer: chief financial officer | S-Sale | 10,614 | $2.69 | $29K | Filing |
| 2025-06-13 | Ogden Christopher | officer: chief financial officer | S-Sale | 1,641 | $2.95 | $5K | Filing |
| 2025-03-18 | BELVIN MARCIA | officer: svp, chief scientific officer | S-Sale | 19,512 | $0.60 | $12K | Filing |
| 2025-03-18 | Chu Yu-Waye | officer: chief medical officer | S-Sale | 4,025 | $0.60 | $2K | Filing |
| 2025-03-18 | ROWLAND LLOYD A | officer: general counsel | S-Sale | 10,203 | $0.60 | $6K | Filing |
| 2025-03-18 | Ogden Christopher | officer: chief financial officer | S-Sale | 8,551 | $0.60 | $5K | Filing |
| 2025-03-18 | McCarthy Sean A. | officer: ceo | S-Sale | 37,656 | $0.60 | $23K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| FMR LLC | 32,714,937 | $123M | +759,300 | 2026-06-30 | Filing |
| Kynam Capital Management, LP | 21,703,093 | $81M | +6,690,000 | 2026-06-30 | Filing |
| BlackRock, Inc. | 17,559,822 | $66M | +12,331,542 | 2026-06-30 | Filing |
| BANK OF AMERICA CORP /DE | 15,082,617 | $57M | +4,879,832 | 2026-06-30 | Filing |
| STATE STREET CORP | 11,747,236 | $44M | +6,083,828 | 2026-06-30 | Filing |
| PERCEPTIVE ADVISORS LLC | 10,439,185 | $39M | +340,361 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 8,525,457 | $32M | -207,661 | 2026-06-30 | Filing |
| Point72 Asset Management, L.P. | 7,811,033 | $29M | -64,357 | 2026-06-30 | Filing |
| WELLINGTON MANAGEMENT GROUP LLP | 5,168,961 | $19M | +1,585,976 | 2026-06-30 | Filing |
| Venrock Adviser, LLC | 4,982,124 | $19M | -5,000,000 | 2026-06-30 | Filing |
| BAKER BROS. ADVISORS LP | 4,975,826 | $19M | — | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 4,678,716 | $18M | +2,612,104 | 2026-06-30 | Filing |
| Elmind Capital, LP | 4,550,000 | $17M | — | 2026-06-30 | Filing |
| Nextech Invest Ltd. | 4,449,932 | $17M | — | 2026-06-30 | Filing |
| TWO SIGMA INVESTMENTS, LP | 4,132,643 | $15M | +1,422,487 | 2026-06-30 | Filing |
| Eversept Partners, LP | 3,558,497 | $13M | +369,983 | 2026-06-30 | Filing |
| UBS Group AG | 3,468,359 | $13M | +348,204 | 2026-06-30 | Filing |
| Siren, L.L.C. | 3,457,711 | $13M | — | 2026-06-30 | Filing |
| ADAR1 Capital Management, LLC | 3,365,118 | $13M | -45,072 | 2026-06-30 | Filing |
| CITADEL ADVISORS LLC | 3,110,509 | $12M | -2,295,684 | 2026-06-30 | Filing |